生物混合系统 EcN@PB用于重塑瘤免疫抑制微环境,以改善光热疗法诱导的抗瘤免疫反应
Qiang Feng1,2,3,4, Hui Zhang2,3,4, Guixian Ye1,2,3,4
1Innovation Center for Cancer Research, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, PR China.
Materials today. Bio
|November 24, 2025
概括
这项研究介绍了EcN@PB,这是一种增强光热疗法 (PTT) 和免疫疗法的新系统. EcN@PB改善了普鲁士蓝向瘤的输送,导致有效的癌症治疗和减少复发.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫治疗是一种免疫疗法.
背景情况:
- 光热疗法 (PTT) 提供向性瘤切除,副作用较低.
- 普鲁士蓝 (PB) 对PTT有效,但在瘤中面临交付挑战.
- 通过免疫细胞死亡 (ICD) 激活抗瘤免疫对于有效的癌症治疗至关重要.
研究的目的:
- 开发一种新的生物混合系统,EcN@PB,用于增强的普鲁士蓝介导光热免疫疗法.
- 克服PB在瘤中的积累和扩散的局限性.
- 为了利用EcN的免疫辅助特性,改善抗瘤免疫反应.
主要方法:
- 构建 EcN@PB 生物混合系统以实现有针对性的交付.
- 在携带瘤的小鼠模型中评估 EcN@PB 积累和光热剥离.
- 评估免疫反应,包括ICD,树突细胞成熟,T细胞透和巨细胞两极分化.
主要成果:
- EcN@PB证明了选择性瘤积累和高效的光热剥离.
- 由EcN@PB介导的PTT诱导了瘤细胞ICD并重塑了瘤免疫微环境.
- EcN@PB激活了全身抗瘤免疫力,抑制了初级和远程瘤的生长,并预防了复发.
结论:
- EcN@PB生物混合系统显著提高了光热免疫治疗的PB输送.
- EcN@PB有效地将光热切除与免疫激活相结合,用于全面的癌症治疗.
- 这一策略显示出克服瘤治疗障碍和改善治疗结果的前景.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K